COVID-19 en el embarazo y la lactancia materna
Resumen
El COVID-19 representa una crisis global, debido a que es una enfermedad emergente con un rápido aumento de casos y muertes desde su primera identificaciòn en Wuhan, China en diciembre de 2019. En medio de este brote se ha centrado la atenciòn en un grupo vulnerable de personas, las embarazadas. Se ha descrito que el virus SARS-coV-2 tiene predilecciòn por el receptor ECA2 presente a nivel placentario, condicionando una restricciòn al crecimiento intrauterino y/o parto pretérmino. Aunado a lo anterior se han planteado preocupaciones sobre si el virus del SARS-CoV-2 podría transmitirse de la madre positiva al COVID-19 al recién nacido a través de la leche materna. Es por ello, que en este trabajo se abordó una recopilación de resultados de estudios epidemiológicos sobre los efectos del COVID-19 durante el embarazo y lactancia materna.
Descargas
Citas
Borges Cavalcante M., Torres de Melo Bezerra Cavalcante C., & Sampaio Braga A. C. COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding. Geburtshilfe Frauenheilkd, 2021, 81(01): 46-60.
Kotlar Bethany, Emily Gerson, Sophia Petrillo, Ana Langer , & Henning Tiemeier. The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reproductive Health volume, 2021, 18 (10): 1-39.
DeBolt CA., Bianco A, L, Limaye MA, Silverstein J., Penfield CA., Roman AS, . . . Bernstein. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obst Gynecol 2019; XX (xx): xx-xx.
Delahoy MJ. (2020). Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19-COVID-NET, 13 States, March 1–August 22, 2020. Morbidity and Mortality Weekly Report: MMWR, 2020; 69 (38): 1347-1354.
Harshil Bhatt. Should COVID-19 Mother Breastfeed her Newborn Child? A Literature Review on the Safety of Breastfeeding for Pregnant Women with COVID-19. Maternal and Childhood Nutrition, 2021;50-62.
Khalil A., Von Dadelszen P., Draycott T., & Ugwumadu A. Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA, 2020, 324 (7): 705-706.
Muralidar S., Ambi SV., Sekaran S, & Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARSCoV-. Biochimie, 2020, 85-100.
Wu C., Yang W., Wu X., Zhang T., Zhao Y., Ren W., & Xia J. Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women. Virologica Sinica, 2020, 35 (16): 305-310.
Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Meaney-Delman D. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3, 2020. Morbidity and Mortality Weekly Report, 2020, 69 (44); 1641–1647.
